World Leading Speakers
Kate Adcock, Director Of Research And Innovation, The Muscular Dystrophy U.K.
Ion Agirrezabal, Senior Consultant, Covance Market Access And Phase Iv Solutions, Covance Market Access
Tanya Aiden, Global Products Lead, BIOCAD
John Alter, Vice President Pricing And Market Access, Pfizer
Mauricio Alvarez Reyes, Independent, Independent
Sofie Alverlind, Project Manager, Swedish Association of Local Authorities and Regions
Ines Alves, President, ANDO Portugal
Einar Andreassen, Senior Adviser, Hta And Reimbursement, Norwegian Medicines Agency
Diego Ardigo, R&D Rare Diseases Unit Head, Chiesi Farmaceutici SpA
Francis Arickx, Head Of The Directorate Reimbursement Of Medicines And Pharmaceutical Policy, NIHDI - INAMI Belgium
Ramesh Arjunji, Senior Director Heor And Rwe, AveXis
Nadeem Ashraf, Medical Advisor - Diabetes, N/A
Kagan Atikeler, Researcher, Utrecht University
Dorthe Bartels, Strategic Adviser, Amgros
Alex Bastian, Vice President, Value And Market Access, Galapagos NV
Antje Behring, Acting Head, Federal Joint Committee
Igor Beitia Ortiz De Zárate, Director Market Access Southern Europe Region, PTC Therapeutics
Tatyana Benisheva, Professor In Drug Regulatory Affairs, Bulgarian Association For Drug Information
Niri Bhimsan, Head - Health Technology Assessment, Discovery Health
Nadia Bodkin, Rare Disease Advocacy Professional, Rare Advocacy Movement
Axel Boehnke, Director Market Access Eu North, PTC Therapeutics
Luc Boileau, Chairman And Chief Executive Officer, INESSS
Trishal Boodhna, Senior Health Economist, Consulting at McCann Health
Hassan Bruneo, Associate Director, Alnylam Switzerland Gmbh
Anna Bucsics, Project Advisor, Mechanism of Coordinated Access to orphan medicinal products (MoCA)
Rob Burley, Director Of Campaigns, Care And Support, The Muscular Dystrophy U.K.
Bradley Burnam, Chief Executive Officer, Turn Therapeutics
Nicki Catterick, Senior Director, Global Market Access And Pricing, Merck Group
David Catterick, Head Of Market Access Uk, Amgen
Sandro Cesaro-Tadic, Head Pricing I8 And Product Pricing Strategies, Roche
Mark Chalmers, Director Life Sciences, Navigant – A Guidehouse Company
Ali Ciger, Commercial Director, Pain, Pfizer
Francesca Cook, Senior Director, Global Head Of Pricing And Market Access, Regenxbio
Catherine Coulouvrat, Health Value Translation Director, R&D, Sanofi
Warren Cowell, Market Access Director, Shionogi Inc
Francis Crawley, Executive Director, Strategic Initiative For Developing Capacity In Ethical Review (Sidcer), Good Clinical Practice Alliance (GCPA)
Alan Crowther, General Manager, EVERSANA
Marcin Czech, Former Vice Minister, Ministry of Health Poland
Omar Dabbous, Vice President, Health Economics And Outcomes Research, AveXis
Charles De Cidrac, Director Of Health Insurance, AXA
Erwin De Cock, Principal, Late Stage, Syneos Health
Gerard De Pouvourville, Professor And Chairman, Health Economics And Management, ESSEC Business School
Rob De With, Head of Rare Diseases for Europe and Canada, Takeda
Carla Deakin, Programme Director - Commercial And Managed Access, NICE
Olga Diachenko, Market Access Manager Europe, Accord Healthcare
Valentin Dodonov, Deputy General Head Of Market Access, BIOCAD
Mark Duman, Nw Service Champion, Diabetes U.K.
Jenny Ebert, National Account Director, Genzyme Sanofi Corp
David Elvira, Heads Eu Public Affairs, Sanofi
Gottfried Endel, Ebm, Hta Team Leader, Austrian Social Insurance
Michael Ermisch, Specialist, Department Of Pharmaceuticals, G.K.V. Spitzenverband
Jaime Espin, Professor, Andalusian School Of Public Health
Gina Ewy, Head Of Global Market Access, Hansa Biopharma
Valerie Faillat, Head Of Sanofi Espoir Foundation, Sanofi
Diar Fattah, Global Director, Innovative Value Strategies And Evidence (Respiratory), AstraZeneca
Girisha Fernando, Chief Executive Officer, Lyfegen HealthTech AG
Steven Flostrand, Senior Director Of Pricing And Market Access, Celgene
Douglas Foerster, Head Market Access Europe And Row, Santhera
Jonathan Galduf, Market Access Manager, Sun Pharmaceutical Industries Limited
Benjamin Gannon, Vice President International Access, Policy And Advocacy, Myriad genetics
Sandra Garitonandía, Business Development Manager, Vistex
Oliver Gassner, Head G4A Digital Health Intelligence Emea, Bayer
Fabrizio Gianfrate, Professor Of Health Economics, Market Access Advisor, Universities of Rome and Ferrara
Josie Godfrey, Director, JG Zebra Consulting
Wim Goettsch, Special Hta-Advisor, Zorginstituut
Alex Grosvenor, Vice President, Global Pricing and Market Access, Precision Xtract
Marcus Guardian, Chief Operating Officer, EUnetHTA
Clare Hague, Therapy Area Market Access Lead, Hematology, Janssen Pharmaceutical
Alfred Harvey, Associate Director, Health Economics And Outcomes Research, Becton Dickinson
Adam Heathfield, Senior Director Of Global Health And Value Innovation Centre, Pfizer Ltd
Ezequiel Heredia, Consultant, Lifescience Dynamics Ltd
Ramon Hernandez Vecino, Head Of Real World Evidence Data And Analytics Engagement Lead Randd, Sanofi
Hans Hofstraat, Vice President, Philips Research
Stefan Holmstrom, Head, Hta Strategy And Pro Excellence, Astellas Pharma
Birgit Holz, Global Head Of Contracting Innovation, Sanofi
Francois Houyez, Treatment Information And Access Director, Health Policy Advisor, EURORDIS
Alison Howell, Director, Covance
Wills Hughes-Wilson, Head Of Patient Access And Commercial Planning, Mereo BioPharma
Carlo Incerti, Operating Partner, Forbion
Ulrike Jacobi, Head Of External Affairs And Market Access, Amgen
Ashley Jaksa, Vice President Of Analytics Solutions, Aetion, Inc.
Rasmus Jensen, Global Head Of Market Access, Camurus
Elizabeth Johnson, Biologics Coordinator, Allergy Partners, P.A.
Calum Jones, Senior Consultant - Evidence, Value And Access (Heor), Consulting at McCann Health
Rosemary Jose, Director And Commercial Lead, Strategic Market Access, Pharmerit International
Marcela Junqueira, Head Of Strategic Affairs And Health Economics, Janssen Pharmaceutical
Madhusudan Kabra, Director, Evidence Generation, Otsuka Pharmaceutical
Gomathi Kaliappan, Global Market Access - Health Systems Strategy, Value Recognition, Roche
Diane Kleinermans, Advisor To The Ministry Of Health And Social Affairs, Belgian Federal Government
Alison Kneen, SVP & Head of DRG Abacus, Decision Resources Group
Jolanda Koenders, Head Of Patient Value And Access, Takeda
Shanthy Krishnaraja, Senior Director, Market Access And Strategy, Seqirus
Adam Kundzewicz, Senior Global Payer Strategy Manager, Head Of Pricing, Boehringer Ingelheim Pharma GmbH & Co. KG
Dylan Lamb-Palmer, Manager, Pricing and Data Analytics, PDCI Market Access Inc
Marie-Liesse Le Corfec, Global Portfolio Marketing Head, Ps, B.D. Pharmaceuticals Systems
Jost Leemhuis, Head Of Safety Science, Roche
Timothy Lenehan, Senior Director - Global Value And Access, Biogen
Giovanny Leon, P&Ma Director, Novartis AG
Bruno Leroy, Vice President, Global Head Of Health Value Translation, Sanofi
Friedhelm Leverkus, Director Health Technology Assessment And Outcomes Research, Pfizer
Gavin Lewis, Vice President For Value, Access And Policy, Amgen
Herve Lilliu, Chief Executive Officer, inbeeo
Sune Lindgaard, Chief Of Business Intelligence, Amgros, Denmark
Yannick Loonus, Chief Sales Officer, Semalytix GmbH
Catarina Lopes Pereira, Global Market Access Manager, Medac
Kevin Loth, Vice President, Corporate Affairs And Policy, Worldwide Markets, Celgene
Elena Lungu, Manager Of Policy Development, Government of Canada (Canada)
Alastair Macdonald, Senior Vice President Of Real World And Late Phase, Syneos Health
Mark Macgregor, Medical Director, Golden Jubilee National Hospital
Steinar Madsen, Medical Director, Norwegian Medicines Agency, Norway
Joerg Mahlich, Heor, Janssen Pharmaceutical K.K.
Andrea Mantovani, Former Market Access Executive, Independent
Marco Marchetti, Director Of The National Center For Health Technology Assessment, Istituto Superiore di Sanita
Anne Marciniak, Head Of Market Access, Europe, Aimmune
Cristina Martin-Rinconada, Head Of Value And Access For International Partners Markets (Mena And Ceer Regions), Biogen
Vipul Modi, Head Of Transformation For Innovation, Digital And Life Sciences, Oxford Academic Health Science Network
Patrick Mollon, Heor Consultant, Gmap, Ipsen Pharma
Paolo Morgese, Director, Market Access And Member Relations, Alliance for Regenerative Medicine
Thomas Mueller, Head Of Directorate General 1 - Drugs, Medical Devices, Biotechnology, Federal Ministry of Health Germany
Michael Muller, Head Of Market Access, Western Europe, Sun Pharma
Diane Munch, Vice President, Global Pricing, Patient And Health Impact, Pfizer
Nuriya Musina, Head Of Development, Federal State Budgetary Institution, The Center For Healthcare Quality Assessme, Ministry of Health Russian Federation
Anushini Muthutantri, Director, Evidence, Value And Access, Consulting at McCann Health
Sue Naeyaert, Advisor, Idependent
Hanadi Nahas, Chairman And General Manager, Access Core
Inez Naidu, Head - Discovery Health Medicines Unit, Discovery Health
Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (Belgium)
Noluthando Nematswerani, Head - Centre For Clinical Excellence, Discovery Health
Claudia Neuber, Head Of Global Pricing Implementation, AstraZeneca
Irina Odnoletkova, Vice President Health Technology Assessment, Apogenix Gmbh
Dapo Ogunbayo, Programme Manager - Healthcare Innovations (Pharmaceuticals), NIHR Innovation Observatory, Newcastle University
Melvin Olson, Global Head Rwd Strategy And Innovation, Novartis Pharma
Amer Omar, Senior Director, Lupin
Nneka Onwudiwe, Founder And Chief Executive Officer, Pharmaceutical Economics Consultants of America (PECA) LLC
Mario Ouwens, Senior Statistical Science Director, Astra Zeneca
Ana Palma, Senior Director Global Hta And Patient Access Lead, Sobi
Elena Panitti, Global Rwe Capability Building Lead, Novartis
Detlev Parow, Head Pharmaceutical Department, D.A.K.
Chris Pashos, Former Vice President Of Global Evidence Strategy, AbbVie
Julien Patris, Associate Director Of Market Access And Policy For Europe And Canada, Alnylam
Marco Penske, Head Of Market Access And Health Care Affairs, Boehringer-Ingelheim
Ed Pezalla, Former Vice President, National Medical Director For Pharmaceutical Policy And Strategy, Aetna; a CVS Pharmacy Health Company
Andres Pichon Riviere, Executive Director And Director Of Health Technology Assessment And Economic Evaluations, I.E.C.S.
Sagie Pillay, Chief Operating Officer, Wits Health Consortium
Oresta Piniazhko, Director, Hta Department, Ministry of Health of Ukraine
Carme Pinyol, Head Of Pricing And Market Access Southern Europe, Pierre Fabre
Lara Pippo, Head Of Market Access, CSL Behring
Sarah Pitluck, Head, Global Pricing And Reimbursement, Spark Therapeutics
Adam Plich, Managing Director, Plich Advisory
Mary Lynne Van Poelgeest-Pomfret, President, President of the World Federation for Incontinence and Pelvic Pain - WFIP
Angelina Irizari Policarpio, Head Of Heor And Real World Evidence Communications, Eisai
Caridad Pontes, Manager Of Pharmacotherapeutic Harmonization, Catalan Health Service
Robert Popovian, Vice President Of Government Relations, Pfizer
Diann Potestio, Vice President Market Access, Ascendis Pharma
Martin Price, Vice President Of Health Economics, Market Access And Reimbursement, Johnson & Johnson
Nuno Prego Ramos, Chief Executive Officer, CellmAbs
Isabell Remus, Head Biopharmaceuticals Europe, Sandoz
Andreia Ribeiro, Director, Lifescience Dynamics Ltd
Kevin Rieger, Head Of Public And Governmental Affairs Dach, Ipsen Pharma Gmbh
Giuseppe Rosano, Member Of The Cardiovascular Working Party, European Medicines Agency
Micah Rose, Senior Scientific Adviser, Health Economic Modelling, National Institute for Health and Care Excellence
Igor Rudychev, Head Of Us Digital, Data, And Innovations, AstraZeneca
Marcelo Sal, Head of Market Access and Pricing, Argentina, PTC Therapeutics
Yves Samel, Market Access Strategy Leader And Global Pricing Manager, Bayer
Steve Sandor, Vice President, Market Access And Trade, Paratek Pharmaceuticals , Inc.
Gustavo Saraiva Dos Anjos, Global Market Access Director For Biologics, GlaxoSmithKline
Gundula Schneidewind, Head Ethics And Compliance, Europe And Canada, Takeda
Michael Schroter, Partner, Viopas Partners
Mitch Scurtu, President, Global Technologies
Nabil Seidov, Deputy Head Of Department For Health Policy And Planning Of Public Health And Reforms Centre, Ministry of Healthcare of Azerbaijan Republic
Ayman Semaan, Market Access, Algorithm
Maja Sercic, Policy & Science Manager, Medicines for Europe
Simon Shohet, Head Of International Market Access, Amicus Therapeutics
Rita Shorjian, Market Access Head - Near East And North West Africa, AbbVie
Dorinda Silva, Volunteer Patient Advocate, Portuguese Association for CDG and other Rare Metabolic Diseases
Tamir Singer, Head Of Commercial Development, Specialised Commissioning, NHS England
Stefan Sladecek, Head Of Market Access Austria, Roche Diagnostics
Sebastian Soluch, Head Of Market Access And Pricing, Europe, Stemline Therapeutics Inc
Richard Stephens, Patient Advocate, Independant
Lotte Steuten, Vice President And Head Of Consulting, Office of Health Economics
Magdi Stino, Product Manager, EVERSANA
Giovanni Tafuri, Eunethta, Senior Scientific Officer, National Health Care Institute (ZIN), the Netherlands
Luqman Tariq, Market Access Director, Europe, Stryker Corp
Samuel Taylor, Emerging Markets Pricing Lead, Pfizer
Renske Ten Ham, Researcher, Utrecht University
Bharat Tewarie, Executive Vice President And Chief Marketing Officer, UCB
David Thompson, Senior Vice President, Head Of Thought Leadership, Real World And Late Phase Research, Syneos Health
Daria Tolkacheva, Head Of Health Economics, JSC BIOCAD
Jorg Tomeczkowski, Head Of Market Access, Janssen Cilag Germany
Oleksandr Topachevskyi, Essential Medicines List Committee Member, Ministry of Health of Ukraine
Jasim Uddin, Head of Evidence, Value & Access, Consulting at McCann Health
Sheela Upadhyaya, Associate Director Hst, National Institute for Health and Care Excellence
Inneke Van De Vijver, Strategic Advisor - Reimbursement Pharmaceuticals, N.I.H.D.I.
Erik Van Den Berg, Chief Executive Officer, A.M. Pharma
Bart Van Den Daele, Head Of External Affairs - Director Market Access, Gilead Sciences
Goedele Van Haasteren, Hta Specialist, Swiss Federal Office of Public Health
Evert Jan Van Lente, Director Eu-Affairs, AOK Bundesverdand
Christina Vandoros, Director, Macroeconomics And Health Policy - Emea, Janssen
Stefan Vegter, Market Access Manager, Novartis
Kart Veliste, Chief Specialist At Department Of Medicines And Medical Devices, Haigekassa Estonia
Marijn Verhoef, Engagement Manager, Access to Medicine Foundation
Bart Vermeulen, Deputy Director Healthcare At Office Of The Minister Of Social Affairs And Public Health, Belgian Federal Government
Jaume Vidal, Policy Advisor, Eu Projects, Health Action International
Reg Waldeck, Market Access Strategy Leader, Bayer Corp
Rebecca Walker, Director, Global Access Strategy, UCB Pharma
Amy Wang, Managing Consultant, Navigant – A Guidehouse Company
David Watson, Executive Director, Economic, Health and Commercial Policy, ABPI
Lindsay Weaver, Chief Executive Officer, Metabolic Support UK
Keith White, Vice President And Head, Global Market Access, Corbus Pharmaceuticals
Alexander Wilke, Director Market Access And Public Affairs (D-A-Ch), Ipsen
Anne Willemsen, Project Manager Eunethta, Zorginstituut Nederland / EUnetHTA
Bryon Wornson, Vice President, Global Health And Value, Pfizer Oncology
Natasa Zibelnik, Global Head Of Market Access, E.U.S.A. Pharma
Martine Zimmermann, Global Head Of Regulatory Affairs, Alexion Pharmaceuticals
Fabrizio Zucca, Director Market Access Dach, Intercept Pharmaceuticals Inc
Contact us
To sponsor or exhibit:
Edmond Rama
+44 (0)207 092 1052
edmond.rama@terrapinn.com
To speak:
Chris Shanks
+44 (0)207 092 1151
chris.shanks@terrapinn.com
Organiser
